Herspiegel Consulting

Industry Leader – Pharmaceutical & Biotech Consulting

We are a full service pharmaceutical and biotech consulting firm that specializes in new product planning and commercial expertise to optimize product launches and brand performance. Our diverse team has a combined 100+ years of extensive corporate, client and consulting experience in biopharmaceuticals. We leverage our expertise to solve critical business issues, deliver innovative solutions and develop best-in-class deliverables to optimize the value of your brands.

At Herspiegel Consulting, we offer a range of integrative pharmaceutical consulting services, tailored and scaled to meet your brand and business’ needs across a wide variety of therapeutic areas. Our services include pharmaceutical new product planning, product launch preparation, marketing excellence, market access strategy, and market shaping. Industry focus and depth of functional expertise, combined with strong scientific and market knowledge, uniquely position our team to develop achievable strategies and solutions for our clients.

Pharmaceutical marketing capabilities

Explore Our Capabilities

Learn how our customized services can help you meet your brand goals.

Pharmaceutical marketing our perspectives

Hear Our Perspectives

Read our blogs and white papers to learn what’s happening in the healthcare industry.

Pharmaceutical marketing get in touch

Get In Touch

Contact us to learn how Herspiegel Consulting can help your organization.

Latest Blogs

The FDA approved Dupixent for moderate-to-severe atopic dermatitis

April 14, 2017
  The FDA approved Dupixent On March 28th, the FDA approved Dupixent for moderate-to-severe atopic ...
Read more

Why Drug Pricing is in the News Now and What Can Be Done About It?

March 3, 2017
Why drug pricing is in the news now and what can be done about it? From Turing Pharmaceuticals to Mylan,...
Read more

Key Challenges Facing Obamacare Repeal and Replace Plan

February 3, 2017
ACA repeal and replacement complicated by two key challenges...
Read more

How Pharma Can Prepare for the Patent Cliff

February 2, 2017
Extending market exclusivity and responding properly to the volume of recent patent expiries are critica...
Read more